|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date28 Apr 1998 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
[Translation] JC002 Postprandial Comparative Pharmacokinetic Clinical Trial
主要研究目的:评价餐后状态下JC002与对照制剂的药代动力学差异及高脂餐食对药代动力学的影响。 次要研究目的:研究受试制剂和对照制剂在健康成人受试者中的安全性
[Translation] The main purpose of the study is to evaluate the pharmacokinetic differences between JC002 and the control formulation in the postprandial state and the effect of a high-fat meal on pharmacokinetics. The secondary purpose of the study is to study the safety of the test formulation and the control formulation in healthy adult subjects.
[Translation] JC002 comparative pharmacokinetic clinical trial
主要研究目的:评价空腹状态下JC002药代动力学的特性。
次要研究目的:评价JC002服用口感与已上市对照制剂是否存在差异;并观察JC002在健康成人受试者中的安全性。
[Translation] The main purpose of the study is to evaluate the pharmacokinetic characteristics of JC002 in the fasting state.
The secondary purpose of the study is to evaluate whether the taste of JC002 is different from that of the marketed control preparation; and to observe the safety of JC002 in healthy adult subjects.
[Translation] JC001 bioequivalence study (high dose group)
验证高剂量JC001与800mg布洛芬注射液BE等效
[Translation] Verify the BE equivalence between high-dose JC001 and 800mg ibuprofen injection
100 Clinical Results associated with Beijing Join Chain Medicine Co., Ltd.
0 Patents (Medical) associated with Beijing Join Chain Medicine Co., Ltd.
100 Deals associated with Beijing Join Chain Medicine Co., Ltd.
100 Translational Medicine associated with Beijing Join Chain Medicine Co., Ltd.